Clinical Trial Update: An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism [Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 3 extension study evaluating enclomiphene citrate for men with secondary hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Enclomiphene Citrate (enclomiphene citrate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Secondary Hypogonadism | Phase 3 | Status: COMPLETED